CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- 424B5 Offering Prospectus
- S-3/A Offering Registration Statement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B4 Offering Prospectus
Page 1 of 2 · 35 filings